Phase IB/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313 - Ramanathan, R K; McDonough, S L; Philip, P A (J Clin Oncol, 2019)
et al.